Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada.
Program in Neuroscience and Mental Health, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
Ann Neurol. 2024 Aug;96(2):405-411. doi: 10.1002/ana.26956. Epub 2024 Jun 1.
Outcomes following vagus nerve stimulation (VNS) improve over years after implantation in children with drug-resistant epilepsy. The added value of deep brain stimulation (DBS) instead of continued VNS optimization is unknown. In a prospective, non-blinded, randomized patient preference trial of 18 children (aged 8-17 years) who did not respond to VNS after at least 1 year, add-on DBS resulted in greater seizure reduction compared with an additional year of VNS optimization (51.9% vs. 12.3%, p = 0.047). Add-on DBS also resulted in less bothersome seizures (p = 0.03), but no change in quality of life. DBS may be considered earlier for childhood epilepsy after non-response to VNS. ANN NEUROL 2024;96:405-411.
植入迷走神经刺激器(VNS)多年后,耐药性癫痫患儿的治疗效果会逐渐改善。与持续优化 VNS 相比,深部脑刺激(DBS)的附加价值尚不清楚。在一项前瞻性、非盲、随机患者偏好试验中,18 名对 VNS 治疗至少 1 年后无反应的儿童(年龄 8-17 岁)接受了附加 DBS 治疗,与再进行 1 年 VNS 优化相比,DBS 治疗导致癫痫发作减少(51.9% 对 12.3%,p=0.047)。附加 DBS 还导致癫痫发作次数减少(p=0.03),但生活质量无变化。在对 VNS 治疗无反应的情况下,DBS 可更早用于儿童癫痫的治疗。神经病学年鉴 2024;96:405-411。